Valentina Agostoni

Valentina Agostoni is a Senior Associate at TVM Capital Life Science. Prior to that, Valentina worked as a Preclinical Development Scientist at Mperia Therapeutics Inc and Versantis AG. Valentina has a background in Pharmaceutical Sciences and Biomedical Sciences, with a focus on nanoscale drug delivery systems and CAR T-cell therapy. Valentina holds a PhD from Université Paris-Saclay and has conducted research on identifying molecular markers for renal carcinoma.